AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on the overdose epidemic from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on the overdose epidemic from PolicyFinder
AMA in Action: Ending the overdose epidemic

End the Epidemic website
Clear Search
·
2 Min Read

July 30, 2021: State Advocacy Update

Educating prescribers and medical students about buprenorphine treatment for OUD and more in the latest State Advocacy Update.

Advocacy Update
·
4 Min Read

AMA backs update to CDC opioid prescribing guidelines

The AMA is urging the CDC to remove arbitrary thresholds, restore balance and support comprehensive, compassionate care as it revises the guidelines.

Press Releases
Pharmacist holding a packaged prescription
·
6 Min Read

When arbitrary policies collide with patient care

Correcting a national pharmacy chain’s misinterpretation of CDC opioid-prescribing guidelines turned into a six-month headache for an Illinois doctor.

Behavioral Health
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of July 12, 2021

In the news: Johnson & Johnson vaccine and Guillain-Barré, COVID infections doubled in three weeks, CDC reports 29% increase in overdose deaths, additional COVID shots for immunocompromised.

Publications & Newsletters
·
2 Min Read

Rhode Island is first state to support pilot harm reduction center

AMA strongly supports efforts to reduce drug-related overdose and death.

Press Releases
Open doors of a cell in a correctional facility or prison.
·
4 Min Read

Require access to Rx for opioid-use disorder in prisons, jails

Delegates seek to ensure that evidence-based treatment for substance-use disorders, along with social support, is available in correctional facilities and upon release.

Population Health
Naloxone spray
·
3 Min Read

Biden administration boosts access to overdose prevention, treatment

The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.

Behavioral Health
Pedestrians crossing the street
·
4 Min Read

Removing stigma, advancing evidence-based care at Mount Sinai

Learn about an innovative primary care program at the New York hospital that helps people with opioid-use disorder get the care they need.

Behavioral Health
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases